A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular Carcinoma
Clinical trial NCT02528643 · COMPLETED
Trial details
- NCT number
- NCT02528643
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-09
- Primary completion
- 2017-10-02
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.